Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelial cell calcium entry pathways represent a complex network of channels and sensors that regulate the influx of Ca2+ into the vascular endothelium, a process vital for vascular homeostasis. The primary mechanism is store-operated calcium entry (SOCE), which involves the endoplasmic reticulum Ca2+ sensor STIM1 and the plasma membrane channel ORAI1 [1, 8]. Additionally, various Transient Receptor Potential (TRP) channels, such as TRPV4 and TRPC families, contribute to calcium entry in response to mechanical forces and chemical ligands [2, 5]. These pathways are essential for the activation of endothelial nitric oxide synthase (eNOS), which promotes vasodilation and maintains the endothelial barrier [4, 7]. Dysregulation of these pathways is implicated in diseases such as pulmonary arterial hypertension, where excessive calcium entry promotes endothelial-to-mesenchymal transition, and cancer, where it drives pathological angiogenesis [9, 11]. Therapeutic strategies include the use of small-molecule inhibitors like BTP2 for SOCE or specific TRP channel modulators to restore vascular function [10, 11]. However, the ubiquitous nature of calcium signaling poses challenges for achieving tissue-specific effects without systemic toxicity. Recent advances have identified novel mediators like EB3 that can be targeted to resolve pathological calcium signaling in acute lung injury [10].
Modulation of calcium influx through store-operated (SOCE), receptor-operated (ROCE), and mechanosensitive channels to regulate endothelial function and vascular tone [1, 11].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelial cell calcium entry pathways.